Crf2 receptor agonists and their use in therapy
US-2025243255-A1 · Jul 31, 2025 · US
This page is not indexed by search engines while we improve data quality.
Elvert Ralf patents
Elvert Ralf is listed as an inventor on 9 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Elvert Ralf |
| Total patents | 9 |
| First publication | Nov 5, 2015 |
| Latest publication | Jul 31, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
GLP-1/glucagon receptor agonists in the treatment of fatty liver disease and steatohepatitis
US-11352405-B2 · Jun 7, 2022 · US
Glp-1/glucagon receptor agonists in the treatment of fatty liver disease and steatohepatitis
US-2020216510-A1 · Jul 9, 2020 · US
Exendin-4 derivatives as peptidic dual GLP-1/glucagon receptor agonists
US-9775904-B2 · Oct 3, 2017 · US
Peptidic dual GLP-1/glucagon receptor agonists derived from exendin-4
US-9771406-B2 · Sep 26, 2017 · US
Dual GLP-1/glucagon receptor agonists derived from exendin-4
US-9758561-B2 · Sep 12, 2017 · US
Peptidic dual glp-1/glucagon receptor agonists derived from exendin-4
US-2015322129-A1 · Nov 12, 2015 · US
Dual glp-1/glucagon receptor agonists derived from exendin-4
US-2015322128-A1 · Nov 12, 2015 · US
Exendin-4 derivatives as peptidic dual glp-1/glucagon receptor agonists
US-2015315260-A1 · Nov 5, 2015 · US
Recent patents
Latest publications not already listed above.
No data yet.
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Sanofi Sa | 9 |
Top CPC classifications
Most common classification codes across this inventor's patents.